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Background: To analyze setup deviations using daily megavoltage computed tomography (MVCT) and to evaluate
three MVCT frequency reducing protocols for gynecologic cancer patients treated with helical tomotherapy.
Methods: We recorded the setup errors of 56 patients with gynecological cancer observed throughout their whole
course by matching their daily MVCT with the planning CT. Systematic and random errors were calculated on a
patient and population basis. We defined three different protocols corresponding to MVCTs from the first five
fractions (FFF), the first ten fractions (FTF) or from the first and third weeks (505). We compared theoretical. setup
errors calculated using these 5 or 10 early MVCT scans with the actual errors found with the remaining fractions to
to analyze the residual deviations.
Results: The total systematic (random) deviations had means of −2.0 (3.8)mm, 0.5 (3.4)mm, 0.5 (6.1)mm and −0.5°
(0.9°) in vertical (V), longitudinal (LO), lateral (LA), and roll (R) directions, respectively. The proposed three MVCT
protocols resulted in minor residual deviations. In all three protocols, 95% of all calculated residual deviations were
less than or equal to 5 mm in all 3 directions. When examining the additional minimal CTV-PTV setup margins that
were calculated based on these residual deviations, the 505 protocol would have allowed smaller margins than the
FFF and FTF protocol, particularly in the V direction.
Conclusions: For patients with gynecologic cancer, the 505-protocol led to the lowest residual deviations and
therefore might offer the best approach in reducing the frequency of pre-treatment MVCTs.
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The daily use of image guidance (IGRT) is finding more
frequent application in radiation therapy. Modern
linear and helical tomotherapy (HT) accelerators are
equipped with an onboard imaging device e.g. kV
(kilovoltage; cone-beam) CT scanner or MVCT scanner
(megavoltage) to localize the target and are capable of
applying intensity modulated radiotherapy (IMRT) or volu-
metric modulated arc therapy (VMAT) to deliver highly
conformal dose distributions [1]. HT uses an MVCT
imaging tool [2] and has been established for the treatment* Correspondence: carmen.stromberger@charite.de
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distribution, and reproduction in any mediumof patients with gynecologic malignancies [3,4]. For a
curative radiotherapy or chemoradiation an adequate
treatment of the CTV is essential. The CTV to PTV
margin is an established planning method to enable
appropriate coverage of the target volume. Pelvic
radiotherapy is associated with both an overall higher setup
uncertainty in patient positioning and uncertainties due to
potential internal organ motion (e.g. uterus, rectum, pros-
tate), thus necessitating wide PTV margins. The shrinkage
of the CTV-PTV margin might lead to a reduction of treat-
ment related toxicity (e.g. gastrointestinal) but too narrow
margins will increase the risk of inadequate cancer
treatment, especially for techniques with highly conformal
doses to the target volume. The MVCT of HTallows a daily
patient setup verification and correction prior to eachntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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KV-planning CT and patient repositioning takes sig-
nificant additional time, depending on the image scan
length. This has an impact on patient comfort and
tolerance. In this study we investigated the feasibility
of reducing the frequency of MVCT scans for patients
with gynecological tumors by determining patient and
population based systematic and random errors. Three
different reduced frequency protocols were analyzed with
regard to their respective residual deviations were they to
be used in the daily routine.
Methods
Patients and patient setup
We analyzed data from a total of 56 patients with cervical
cancer, FIGO stage IB-IVA, treated with HT at our institute
from June 2008 to December 2009. Pelvic radiotherapy was
delivered in 48 cases, 8 patients were treated with pelvic
and extended field radiotherapy because of paraaortic
lymph node metastases. A total of 34 patients were treated
with definitive chemoradiation, 22 patients were treated
with an adjuvant radio(chemo)therapy. All patients
were placed in a supine position and immobilized
using a combiboard with knee-ankle fixation (Unger
Medizintechnik, Germany) with their arms folded over their
chest. Planning CT scans (CT scanner LightSpeedW from
GE Healthcare, General Electric Company, NYSE; GE) were
performed at a slice thickness of 3.75 mm.
CTV definition, PTV margins, organ at risks, dose
prescription and planning parameters for definitive chemo-
radiation with or without paraaortic (extended) field irradi-
ation have been described earlier [3]. For postoperative
treatment, the CTV included all regions of potential micro-
scopic disease: the surgical bed, regional lymph node areas
(common, external and internal iliacs and the presacral
region), and the vaginal cuff. The planning target volume
(PTV) was outlined as the CTV plus 1 cm in all directions.
The caudal field border was at the obturator foramen, the
upper field border was individualized on the basis of the
patient’s anatomy to include the common iliac lymph
nodes. Patients were initially positioned by aligning skin
surface markings with the treatment room’s lasers.
Treatment verification
MVCTs were typically acquired before each fraction
allowing a daily patient setup verification and correction.
The scan region and length were defined by the radi-
ation oncologist on the first day of treatment and used
for all future scans. The PTV was not routinely scanned
over its whole length for patients with a paraaortic
extended field. In general, MVCTs were acquired in the
normal mode (slice thickness of 4 mm), with a scan
length between 15–20 cm. The resulting images were
visualized at the HT workstation and the system’ssoftware was used to automatically determine the setup
accuracy. A fine resolution matrix (256 × 256) and a
variation of mutual information registration called
extracted feature fusion based on a mixed “bony and
tissue” anatomy were used to rigidly co-register the
MVCT images with those from the planning CT, a
feature offered by the HT software. Deviations were calcu-
lated in the lateral (LA; x axis), longitudinal (LO; y axis),
vertical (V; z axis) direction and for rotation in the roll
(R; in y axis). Pitch and yaw rotational deviations had
to be kept at 0°, since these could not be corrected
for by couch or gantry manipulations. Deviations in
pitch and yaw rotation were corrected by manually
patient repositioning and controlled with a repeat
MVCT scan. The initial automatic correction was
verified by a radiation oncologist and any necessary
corrections were made using bony structures, the soft
tissue of the cervical region/tumor (definitive treatment)
and PTV localization. Following the registration procedure,
the total deviations were corrected for by a shift of the
treatment couch in the LO, V and LA directions. The
couch used from September 2008 until June 2009 had
to be manually adjusted in the LA direction, but was
later replaced by a fully automatic couch. Rotational,
roll (R) angle was corrected by the fully computerized
alteration of the linear accelerator. Radiotherapy was
delivered in a mean of 28 fractions (range: 27–31),
amounting to a total of 1564 MVCTs.
Calculation of errors and analysis of imaging protocols
The calculation of the systematic and random setup errors
was performed according to the different parameters
published by others [5,6].
The total deviation data in the LO, LA, V, and R
directions, acquired by daily MVCTs prior to treatment
were retrospectively evaluated. These results were used to
generate and compare different protocols for the imaging
frequencies. The first five fractions (FFF) protocol is calcu-
lated on the basis of the patients’ MVCTs acquired on the
first five days of radiotherapy. The averages of the LO, LA
and V deviations (average total deviation per direction)
were calculated and theoretically applied for the subsequent
treatments (23 fractions). This protocol resembles the
FFF-protocol with five image fractions previously described
by Vaandering and colleagues, though this was used for the
treatment of the head and neck and brain region [7]. The
first ten fractions (FTF) protocol is based and calculated on
the patients’ MVCTs acquired during the first ten fractions
(days 1–10). The averages of the detected LO, LA and V
deviations (average total deviation per direction) were
calculated and theoretically applied to the subsequent treat-
ments (18 fractions). The alternate week (505) protocol was
based on the 5 MVCTs on days 1–5 and the 5 MVCT scans
on days 11–15. The scans for fractions 6–10 were not used
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averaged and theoretically applied to the subsequent 13
fractions. For all three protocols, the differences in setup
errors in all four degrees of freedom (residual deviations)
were calculated by subtracting the averaged total deviations
calculated under the specific protocol from the actual devi-
ations detected for the remaining fractions. These residual
deviations were then used to determine cumulative distri-
bution functions (CDF). The CDF is a function describing
the probability that deviations no greater than the associ-
ated deviation (random variable of the CDF) will occur.
The steeper the CDF, the smaller the residual deviation and
the better the MVCT frequency protocol. The CDFs were
determined using built-in functions of Microsoft Excel and
used to compare the three different MVCT protocols.
Furthermore, we calculated the smallest CTV-PTV
margin that is needed if these protocols were applied
according to Van Herk’s formula and McKenzie’s IMRT
assumption: 2.5 Rres (systematic deviation) + 0.7 rres
(random deviation) ensuring that 90% of the patients
receive a minimum dose of 95% to the CTV [5,6,8].
Statistical analysis
Microsoft Excel 2007 and IBM SPSS Version 20 were
utilized to calculate the data and to obtain descriptive
statistics of the patients’ deviations. Student’s two-sided
t-tests were calculated using a significance level of 0.05.
Results
The systematic and random components of all setup de-
viations (LO, LA and V directions) were calculated
allowing the analysis of the mean systematic deviation
(M), the standard deviation of the systematic error (Σ)
and the mean random error (σ) for all patients (Table 1,
Figure 1). Deviations in roll direction were small (Σ =0.7°,
M= −0.5°, σ =0.9°). We did see a negative shift of the
patients’ systematic deviations in the V direction due to a
known upward pitch of the HT couch. This has been
described elsewhere as a 3 mm maximum shift depending
on the longitudinal position of the couch [7].
Residual deviations resulting from the application of
the three imaging frequency protocols are shown in




all systematic deviations (Σ)
Mean of all random
deviations (σ)
LO 0.5 mm 3.7 mm 3.4 mm
V −2.0 mm 5.7 mm 3.8 mm
LA 0.5 mm 4.0 mm 6.1 mm
Total systematic and random deviations prior to correction for gynecologic
patients (n = 56) in the LO, V and LA directions. Shown are the populations’
mean of all systematic deviations (M), the standards deviations of all
systematic deviations (Σ) and the mean of all random deviations (σ).smaller residual deviations in the V and LA direction
compared to the FFF (p < 0.001) and FTF (p < 0.02)
protocol. No significant difference could be seen in the
LO direction. In the FFF and FTF protocol, 5% of the
calculated residual vertical deviations were larger than
3 mm compared to 2% for the 505 protocol. In the FFF
protocol, 95% of the calculated LO residual deviations
were smaller than 4 mm compared to 3 mm for the FTF
or 505 protocol, respectively. The residual LA deviations
in 95% of the FFF and FTF protocol, were calculated to
be smaller or equal to 5 mm compared to 4 mm for the
505 protocol. In all three protocols, 95% of all calculated
residual deviations were less than or equal to 5 mm in
all 3 directions. When examining the additional minimal
CTV-PTV setup margins that were calculated using these
residual deviations, the 505 protocol resulted in smaller
margins than the FFF and FTF protocol, particularly in
the V direction (Table 2).
Discussion
For patients with gynecologic tumors, HT, conventional
IMRT and proton radiotherapy allow normal organ sparing
and highly conformal doses to the target volume, with or
without an additional simultaneous integrated boost to
high-risk areas (e.g. parametria) [3,4,9,10]. An accurate tar-
get delineation, highly reproducible patient immobilization,
and a clear understanding of internal-organ motion and
tumor shrinkage are prerequisites for the optimal use of
these sophisticated techniques on such patients [11-13].
The margin definition has a great impact on DVH parame-
ters for the organs at risk in pelvic radiotherapy, especially
the small bowel [10,14]. Wide range of different CTV-PTV
margins in the treatment of gynecologic malignancies has
been published in the literature [15-17]. Up to now, there is
no generally accepted standard. Furthermore, to the best of
our knowledge, there is not yet sufficient data available to
judge the true usefulness of frequent (daily) image guided
setup correction [15,18-20] and any impact on margin size
or imaging protocols aimed at reducing the frequency of
daily imaging for patients with gynecologic malignancies.
Techniques and acute toxicities of such treatment have
been reported previously [3,9]. A significant inter-fractional
(>3 days) improvement of setup accuracy in the V direction
(not for LO and LA) has been reported, reflecting a
learning curve over time (patient-, technician-wise)
has been reported [18]. The use of 3D-imaging over
the first few days has been suggested [19].
In order to support - or vary - our institutional routine
of using daily MVCTs and a 1 cm CTV to PTV margin
in all directions, we retrospective determined the daily
setup deviations with respect to three different imaging
frequency protocols for 56 gynecologic cancer patients
and analyzed their systematic and random components.










Figure 1 Total systematic and random deviations for gynecologic patients (n = 56) in the LO, V and LA directions. Figures include the
populations’ mean of all systematic deviations (M), the standards deviations of all systematic deviations (Σ) and the mean of all random deviations (σ).































































































Figure 2 Residual deviations of MVCT protocols. Cumulative
distribution of the residual deviations in V, LA and LO directions
persisting when applying the FFF (blue rectangle), the FTF (pink
triangle), the 505 protocol (green dot) for gynecologic tumor
patients. p < 0.05 in V and LA for the 505 protocol.
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the FFF protocol but the 505 led to the best result, where
indeed the images of fraction 10–15 in addition to the first
5 were used for the calculation of our model. Data based
on additional post-treatment MVCT-images seems to
indicate that patient motion contributes less than internal
organ motion to the whole setup error (1.1 ± 1.3 mm
anterior-posterior, -0.3 ± 1.6 mm lateral, 0.2 ± 2.3 mm
cranio-caudal) than internal organ motion does [17].
Although there is inconclusive data on uterus/cervix
organ motion in the literature, patients setup errors
might be reduced to a minimum via daily imaging and
corrections [15]. The decrease in setup error as proposed
by any of our imaging protocols might help to reduce
margins. In all our protocols, 95% of all calculated residual
deviations were less than or equal to 5 mm in all 3
directions. Our results showed that the application of the
505 protocol can lead to smaller (<1 cm) CTV-PTV
margins at least in areas where organ motion is limited
(e.g. vessels/lymph nodes) for definitive and also potentially
for postoperative HT, IMRT or VMAT treatment. Not only
inter-fractional setup errors but also the intra-fractional
movements (organ motion), inter-fractional anatomical
changes (bladder- and rectum filling, small bowel move-
ment), potential changes in BMI and tumor shrinkage need
to be accounted for. Nevertheless, the uterus/cervical
motion, changes in BMI and tumor shrinkage have not
been part of our study. However, a study conducted by
Collen and colleagues [17] investigated the cervical organ
motion in 10 patients with daily MVCTs and found
deviations of −3.5 ± 4.9 mm to the left, 0.2 ± 4.5 mm to the
right, 0.5 ± 10.1 mm in the anterior, -3 ± 6.9 mm in theTable 2 CTV-PTV margins
CTV-PTV margin
(2.5 × Rres (systematic deviation) + 0.7 × rres (random
deviation due to organ motion & set-up error)
v (mm) lo (mm) la (mm) r (°)
Uncorrected 14.9 10.2 11.6 1.9
FFF 8.4 8.8 13.4 1.7
FTF 7.0 6.6 11.5 1.7
505 5.5 6.0 9.2 1.4
The calculated minimal CTV-PTV set-up margins for the vertical (V),
longitudinal (LO), lateral (LA) and angular (R) deviations for three different
MVCT frequency protocols (FFF: first five fractions; FTF: first ten fractions; 505:
on alternate weeks: 1st and 3rd week MVCTs).
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the inferior direction, respectively. Uterus motion seems to
be even more pronounced than cervical movement [16,17].
Taylor et al. found uterus deviations of 2.7 ± 2.8 mm
anterior-posterior, 4.1 ± 4.4 mm superior-inferior and lateral
of 0.3 ± 0.8 mm using MR-imaging on two consecutive
days and they recommended margins of 15 mm (anterior-
posterior), 15 mm (superior-inferior), and 7 mm lateral for
the nodal regions and the parametria [16]. Kaatee et al. [21]
found a large range of cervical organ movements using a
fluoroscopic electronic portal imaging device and radio-
opaque markers. The sigma shifts of the markers in the
anterior-posterior, superior-inferior, and lateral direction
were 3.5, 4.3 and 3.4 mm, respectively. These findings lead
them to recommend margins of 10.5, 12.2 and 9.2 mm.
Van de Bunt and colleagues [22] used MR-images prior to
and after IMRT treatment for cervical cancer patients. The
variations in organ movement they found led to propose
much larger CTV-PTV margins of 24 mm (anterior),
17 mm (posterior), 11 mm (superior), 8 mm (inferior),
12 mm (right) and 16 mm (left). Santanam et al. [15] rec-
ommend a 7 mm CTV-PTV margins in all directions when
using daily imaging and daily setup corrections. Stroom
et al. [23] proposed a 5 mm CTV-PTV margin based on a
study on 14 patients with user defined landmarks (kV, MV
orthogonal Portal imaging). Although a CTV-PTV margin
of 20/10 mm was used in the study, Lim and colleagues
[24] could show that a 5 mm margin might be appropriate
for most patients treated with IMRT with the use of a small
bowel displacement system if daily setup control is used.
The uterus fundus was not part of the CTV in this study.
Furthermore, conflicting data exist on the impact of organ
filling (bladder, rectum) on cervical movement. Some
authors found a correlation between rectum volume/filling
and cervical organ motion [16] and/or no correlation with
bladder filling [16,25] others observed no correlation of
bladder or rectum filling with cervical organ motion [22].
To evaluate the possibility of reducing patients’ “time
on machine” by using protocols that allow less frequent im-
aging but maintaining the higher accuracy offered by IGRT,
a further study is required to look into patient comfort via
quality of life questionnaires. The practical effect of
our protocols on CTV-PTV margins and delivered
dose distributions need to be further analyzed.
Conclusions
This study retrospectively analyzed patient setup deviations
for gynecologic cancer patients. Daily positioning and setup
correction have improved treatment setup accuracy. We
investigated the feasibility of reducing the frequency of pre-
treatment MVCTs by calculating the residual deviations
that would arise when applying three different imaging fre-
quency protocols. The 505 protocol resulted in significantly
smaller residual deviations particularly in the V and LAdirections, but not in the LO direction. An analysis of its
viability, the global impact on cutting down treatment time
and therefore improvements patient comfort are needed to
provide more conclusive evidence for a benefit in treatment
of gynecologic patients.
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